Results 51 to 60 of about 834 (96)
Key clinical message We present a case of primary cutaneous plasmacytosis without systemic involvement. The patient received topical corticosteroids and psoralen plus ultraviolet A therapy, showing significant improvement.
Thanyathorn Nuchanatanon +2 more
doaj +1 more source
Non‐cultured melanocyte‐keratinocyte transplantation combined with narrowband ultraviolet B (NB‐UVB) therapy is a promising and well‐tolerated treatment for facial hypo‐pigmentation following scarring.
Sona Zare +4 more
doaj +1 more source
Edyta Katarzyna Głażewska,1 Marek Niczyporuk,1 Sławomir Ławicki,2 Maciej Szmitkowski,2 Monika Zajkowska,2 Grażyna Ewa Będkowska,3 Andrzej Przylipiak1 1Department of Esthetic Medicine, 2Department of Biochemical Diagnostics, 3Department of Haematological
Głażewska EK +6 more
doaj
Bin Zhou,1,2 Jiachen Gui,2,3 Tao Wang,2,4 Zhimin Li,2 Wenzhi Hu,5 Yue Zhang,2 Qiang Li2 1Graduate School, Hebei North University, Zhangjiakou, People’s Republic of China; 2Department of Dermatology, Air Force Medical Center, PLA, Beijing, People’s ...
Zhou B +6 more
doaj
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Lupus, 2001
This review examines the use of ultraviolet (UV) therapy in lupus erythematosus (LE), a disorder usually associated with abnormally increased photosensitivity. In addition to the abnormal cutaneous response to ultraviolet radiation (UVR) exposure, photo-aggravation of systemic disease activity in systemic LE (SLE) may also occur.
Millard, T P, Hawk, J L M
openaire +2 more sources
This review examines the use of ultraviolet (UV) therapy in lupus erythematosus (LE), a disorder usually associated with abnormally increased photosensitivity. In addition to the abnormal cutaneous response to ultraviolet radiation (UVR) exposure, photo-aggravation of systemic disease activity in systemic LE (SLE) may also occur.
Millard, T P, Hawk, J L M
openaire +2 more sources
Status of ultraviolet A dosimetry in methoxsalen plus ultraviolet A therapy
Journal of the American Academy of Dermatology, 1986The carcinogenic risk of methoxsalen plus ultraviolet A treatment (PUVA) is almost certainly related to the cumulative UVA exposure dose. A reliable estimate of UVA dose is a major component, therefore, in determining the long-term safety of this treatment modality.
B L, Diffey, R, Roelandts
openaire +2 more sources
Psoralens and ultraviolet A therapy of pityriasis lichenoides
Journal of the American Academy of Dermatology, 1984Three patients with long-standing pityriasis lichenoides, which was resistant to other forms of therapy, were successfully treated with PUVA (psoralens and ultraviolet light of wavelength A). One patient had complete clearing of all lesions, and the other two had marked improvement.
F C, Powell, S A, Muller
openaire +2 more sources
Ultraviolet Therapy for Psoriasis
2014Total-body ultraviolet therapy (UV) for moderate-to-severe psoriasis consists of narrowband and broadband-UVB, psoralen plus UVA (PUVA – where psoralen can be ingested orally or applied topically), inpatient phototherapy (i.e. Goeckerman Therapy, Ingram therapy), non-office-based phototherapy (i.e.
Tien V. Nguyen, John Y. M. Koo
openaire +1 more source
2008
Natural sunlight’s beneficial effect on psoriasis has been long known. This observation led over the past century to the utilization of artificial light sources for the treatment of psoriasis. For over seven decades, phototherapy using artificial ultraviolet light has been an established standard in the treatment of psoriasis.
Rahat S. Azfar, Abby S. Van Voorhees
openaire +1 more source
Natural sunlight’s beneficial effect on psoriasis has been long known. This observation led over the past century to the utilization of artificial light sources for the treatment of psoriasis. For over seven decades, phototherapy using artificial ultraviolet light has been an established standard in the treatment of psoriasis.
Rahat S. Azfar, Abby S. Van Voorhees
openaire +1 more source

